Terumo Corporation (TRUMF)

16.79 +0.18 (+1.10%) At close: 11:46AM EDT

Terumo Corporation

2-44-1, Hatagaya
Shibuya-ku
Tokyo 151-0072
Japan
81 3 3374 8111
https://www.terumo.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 30,207

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Shinjiro Sato	Corporate Advisor & Director	794.83k	N/A	1960
Mr. Hikaru Samejima	President, CEO & Director	N/A	N/A	1964
Jin Hagimoto	CFO, CIO, GM of CFO Office, Controller & Treasury Tax Dept., J-SOX Office, IT Planning Dept. & GBS	N/A	N/A	N/A
Shinji Omori	CTO, GM of DX Promotion Dept. R&D Division and Executive Officer	N/A	N/A	N/A
Ms. Miho Mizuguchi	Executive Officer, Chief Legal Officer and GM of CLO Office, Legal & Compliance Department	N/A	N/A	N/A
Tomoko Adachi	Chief Human Resources Officer & Group Executive Officer	N/A	N/A	N/A
Mr. Shoji Hatano	Director & Corporate Advisor	N/A	N/A	1959
James Rushworth	Group Executive Officer & Chief Commercial Officer	N/A	N/A	N/A
Mr. Kazunori Hirose	Director & Group Managing Executive Officer	N/A	N/A	1964
Itaru Sakaguchi	Group Managing Executive Officer	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.

Corporate governance

Terumo Corporation’s ISS governance QualityScore as of 1 April 2024 is 6. The pillar scores are Audit: 1; Board: 5; Shareholder rights: 3; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.